Enveric Biosciences, Inc.
ENVBNasdaqCIK 890821HealthcareFiscal year ends Dec 31
Reports and events: 396 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1416:21 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038418 |
| 2026-08-1416:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038385 |
| 2026-06-0917:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-027976 |
| 2026-06-0917:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027781 |
| 2026-05-2916:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-026364 |
| 2026-05-1508:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023353 |
| 2026-05-1508:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023345 |
| 2026-04-3016:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020410 |
| 2026-04-2018:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-017960 |
| 2026-04-1416:05 ET | DEF 14A | Proxy statementPeriod 2026-04-14 | 0001493152-26-016543 |
| 2026-03-2717:27 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-013294 |
| 2026-03-2717:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013290 |
| 2026-02-1021:28 ET | S-1 | Registration statement | 0001493152-26-005852 |
| 2026-02-0616:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-005606 |
| 2026-01-2817:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-004055 |
| 2026-01-0917:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-001151 |
| 2025-12-1217:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-027541 |
| 2025-12-1112:41 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-027196 |
| 2025-11-1416:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023540 |
| 2025-11-1416:05 ET | 8-K | 8.01 Other events | 0001493152-25-023444 |
| 2025-11-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-023441 |
| 2025-10-2716:30 ET | DEF 14A | Proxy statementPeriod 2025-10-27 | 0001493152-25-019750 |
| 2025-10-2316:30 ET | 8-K | 3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019095 |
| 2025-09-1816:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-014073 |
| 2025-09-0208:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-026143 |
| 2025-08-2917:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-026054 |
| 2025-08-2917:10 ET | 8-K | 3.01 Delisting notice | 0001641172-25-026040 |
| 2025-08-1416:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024021 |
| 2025-08-1408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023724 |
| 2025-06-0316:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-013466 |
| 2025-05-1416:59 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010345 |
| 2025-05-1416:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010275 |
| 2025-04-1509:15 ET | DEF 14A | Proxy statementPeriod 2025-04-15 | 0001641172-25-004717 |
| 2025-04-1414:27 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-004320 |
| 2025-03-3108:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001486 |
| 2025-03-2817:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001296 |
| 2025-03-0609:30 ET | 8-K | 8.01 Other events | 0001493152-25-009336 |
| 2025-02-2608:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-008281 |
| 2025-02-0317:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-004715 |
| 2025-01-3017:10 ET | S-1/A | Registration statement, amended | 0001493152-25-004292 |
| 2025-01-3008:01 ET | S-1/A | Registration statement, amended | 0001493152-25-004213 |
| 2025-01-2706:10 ET | 8-K/A | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-003676 |
| 2025-01-2117:10 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-003091 |
| 2025-01-1417:09 ET | S-1 | Registration statement | 0001493152-25-002214 |
| 2025-01-0316:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-000247 |
| 2024-12-1808:30 ET | DEF 14A | Proxy statementPeriod 2024-12-18 | 0001493152-24-050536 |
| 2024-11-2216:45 ET | 8-K | 3.01 Delisting notice | 0001493152-24-047420 |
| 2024-11-1416:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045859 |
| 2024-11-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045840 |
| 2024-11-1209:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-044572 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.